12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Clinical trial NCT00664859 · COMPLETED
Trial details
- NCT number
- NCT00664859
- Sponsor
- Veloxis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-02-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.